Fourteen states are reporting “high” respiratory virus activity: Arizona, Texas, Oklahoma, Nebraska, Minnesota, Wisconsin, Kentucky, Georgia, Florida, Pennsylvania, Maryland, New Jersey, Delaware and Connecticut.
Two are reporting “very high” levels: Hawaii and New Hampshire.
Here are four more updates:
- Nationally, emergency department visits for influenza and RSV remain high, while COVID-19 ED visits have increased compared to the fall. Flu and RSV test positivity are also elevated, with influenza positivity climbing to 18.8% and COVID-19 positivity steady at 6.6%. RSV test positivity has decreased to 8.9%.
- COVID-19 and influenza A levels in wastewater are high, indicating widespread viral activity. Meanwhile, RSV levels in wastewater remain at a moderate level, signaling a stabilization in many areas, according to the CDC.
- The agency forecasts that influenza-related ED visits will remain at a high to very high level in the coming weeks, while COVID-19 and RSV activity are expected to decrease slightly, though overall respiratory illness activity will remain elevated.
- Vaccination coverage remains a concern, with COVID-19 and influenza vaccine rates still relatively low among U.S. adults and children, particularly for RSV vaccines, which have seen lower uptake.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
